| Name | Title | Contact Details |
|---|
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.
AIMSCO is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
QuickMedical - Medical Equipment and SUpplies is a Issaquah, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nipro Diagnostics is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
At Enclear Therapies, our mission is to halt the progression of disease and extend the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP) by removing toxic proteins that build up in the brain, significantly impacting neurodegeneration.